Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.81 is 636% above its 5-year average of 1.06, around the middle of its 5-year range (0.00–24.40).
As of the fiscal period ended Tuesday, June 30, 2026. 277.19% above its 12-month average of 2.07.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.81.
QUICK RATIO (ACID-TEST)
7.81
QUICK RATIO (ACID-TEST) AVG TTM
2.07
QUICK RATIO (ACID-TEST) AVG 3Y
0.18
QUICK RATIO (ACID-TEST) AVG 5Y
1.06
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+277.19%
CURRENT VS 3Y AVG
+4205.91%
CURRENT VS 5Y AVG
+636.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
+161.36%
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.01M
Quick Ratio (Acid-Test)
7.81
TTM Avg
2.07
3Y Avg
0.18
5Y Avg
1.06
Market Cap
$1.06M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
Market Cap
$1.10M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.27
3Y Avg
2.43
5Y Avg
2.43
Market Cap
$889929.00
Quick Ratio (Acid-Test)
0.46
TTM Avg
3.06
3Y Avg
2.92
5Y Avg
4.33
Market Cap
$885727.00
Quick Ratio (Acid-Test)
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
Market Cap
$879845.00
Quick Ratio (Acid-Test)
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$1.18M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.56
3Y Avg
0.51
5Y Avg
1.01
Market Cap
$817321.00
Quick Ratio (Acid-Test)
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
Market Cap
$1.20M
Quick Ratio (Acid-Test)
0.62
TTM Avg
1.47
3Y Avg
0.74
5Y Avg
0.53
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.01M | 7.81 | 2.07 | 0.18 | 1.06 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | 3.75 | 3.27 | 2.43 | 2.43 |
| GlucoTrack, Inc. (GCTK)vs › | $889929.00 | 0.46 | 3.06 | 2.92 | 4.33 |
| Decoy Therapeutics Inc. (DCOY)vs › | $885727.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Bone Biologics Corporation (BBLG)vs › | $879845.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| IM Cannabis Corp. (IMCC)vs › | $1.18M | 0.46 | 0.56 | 0.51 | 1.01 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $817321.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | 0.62 | 1.47 | 0.74 | 0.53 |
| Genprex, Inc. (GNPX)vs › | $1.33M | 6.77 | 2.33 | 3.65 | 16.80 |
Quick Ratio
7.81
Excludes inventory
Current Ratio
7.99
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.81 |
| 2026-03-31 | 2.14 |
| 2025-12-31 | 0.14 |
| 2025-09-30 | 0.17 |
| 2025-06-30 | 0.09 |
| 2025-03-31 | 0.22 |
| 2024-12-31 | 0.09 |
| 2024-09-30 | 0.01 |
| 2024-06-30 | 0.06 |
| 2024-03-31 | 0.02 |
| 2023-12-31 | 0.20 |
| 2023-09-30 | 0.80 |
| 2023-06-30 | 1.92 |
| 2023-03-31 | 2.54 |
| 2022-12-31 | 3.62 |
| 2022-09-30 | 6.08 |
| 2022-06-30 | 8.25 |
| 2022-03-31 | 24.40 |
| 2021-12-31 | 1.00 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
